The Diagnostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Mortality Among Patients Undergoing Hemodialysis at Rayong Hospital
Keywords:
Neutrophil-to-lymphocyte ratio, Platelet-to-lymphocyte ratio, Hemodialysis, SurvivalAbstract
This study aimed to determine the optimal cut-off values of NLR and PLR and to identify factors associated with mortality among patients undergoing hemodialysis at Rayong Hospital. A retrospective cohort study included patients with ESRD receiving maintenance hemodialysis at Rayong Hospital. Data were obtained from hospital medical records between January 1, 2020 and December 31, 2021, with follow-up until December 31, 2025 to ascertain survival status. A total of 101 patients were included. Descriptive and inferential statistics were applied. Categorical variables were analyzed using the chi-square test or Fisher’s exact test, and continuous variables were compared using the independent t-test, Mann-Whitney-U test. Optimal cut-off values were determined using diagnostic test analysis. Survival analysis was performed, and factors associated with mortality were identified using stepwise Cox proportional hazards regression.
The results demonstrated that, among 101 patients, 27 deaths occurred during follow-up (26.7%), with a median survival of 5.9 years. Regarding discriminatory performance for mortality prediction, the neutrophil-to-lymphocyte ratio (NLR) yielded an area under the receiver operating characteristic curve (AUC) of 0.68, with an optimal cut-off value of 4.93 (sensitivity 50.0%, specificity 82.9%). The platelet-to-lymphocyte ratio (PLR) demonstrated an AUC of 0.62, with a cut-off value of 367.31 (sensitivity 41.2%, specificity 80.6%). In multivariable Cox proportional hazards regression analysis, NLR ≥ 4.93 (adjusted HR 2.75; 95% CI 1.26–5.99) and the presence of cardiovascular disease (adjusted HR 3.05; 95% CI 1.11–8.44) were identified as independent predictors of mortality.
References
Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2018 Oct 1;33(suppl_3):iii28–34. doi:10.1093/ndt/gfy174 PubMed PMID: 30281132; PubMed Central PMCID: PMC6168816.
Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18(6):378–95. doi:10.1038/s41581-022-00542-7 PubMed PMID: 35194215; PubMed Central PMCID: PMC8862002.
Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020 Oct;16(10):573–85. doi:10.1038/s41581-020-0315-4
Xu LC, Zhou FF, Li M, Dai ZW, Cai KD, Zhu BX, et al. Predictive Value of Peripheral Blood Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio on Patient Survival with Peritoneal Dialysis. Clin Lab. 2021 Sep 1;67(9). doi:10.7754/Clin.Lab.2021.210124 PubMed PMID: 34542957.
Zhang Y, Zhang A, Wei L, Ren K, Wang Q, Shao B, et al. A high platelet-to-lymphocyte ratio predicts all-cause mortality and cardiovascular mortality in maintenance hemodialysis patients. Ren Fail. 2023;45(2):2258228. doi:10.1080/0886022X.2023.2258228 PubMed PMID: 37724554; PubMed Central PMCID: PMC10512768.
Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002 Nov;62(5):1524–38. doi:10.1046/j.1523-1755.2002.00600.x PubMed PMID: 12371953.
Yaprak M, Turan MN, Dayanan R, Akın S, Değirmen E, Yıldırım M, et al. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol. 2016 Aug;48(8):1343–8. doi:10.1007/s11255-016-1301-4 PubMed PMID: 27118565.
Catabay C, Obi Y, Streja E, Soohoo M, Park C, Rhee CM, et al. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients. Am J Nephrol. 2017;46(5):408–16. doi:10.1159/000484177 PubMed PMID: 29130984; PubMed Central PMCID: PMC5777311.
Chandrashekar A, Ramakrishnan S, Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206–13. doi:10.4103/0971-4065.132985 PubMed PMID: 25097332; PubMed Central PMCID: PMC4119332.
Shabankhani B, Kazemnejad A, Zaeri F, Espahbodi F, Ahmadi MH, Mirkazemi R, et al. Survival Factors in Patients With End-stage Renal Disease in Mazandaran Province, Iran. Iran J Kidney Dis. 2016 Mar 1;10(2):79.
Yang T, Zhang J, Cao T, Liu C. Platelet-to-lymphocyte ratio as a potential marker for routine management of renal anemia in maintenance hemodialysis patients: A single-center observational study. Medicine (Baltimore). 2026 Jan 9;105(2):e47075. doi:10.1097/MD.0000000000047075
Richardson T, Gardner M, Salani M. Cardiovascular Disease and Dialysis: A Review of the Underlying Mechanisms, Methods of Risk Stratification, and Impact of Dialysis Modality Selection on Cardiovascular Outcomes. Kidney Dial. 2025 Jan 23;5(1). doi:10.3390/kidneydial5010005

